JP2010516763A5 - - Google Patents

Download PDF

Info

Publication number
JP2010516763A5
JP2010516763A5 JP2009547231A JP2009547231A JP2010516763A5 JP 2010516763 A5 JP2010516763 A5 JP 2010516763A5 JP 2009547231 A JP2009547231 A JP 2009547231A JP 2009547231 A JP2009547231 A JP 2009547231A JP 2010516763 A5 JP2010516763 A5 JP 2010516763A5
Authority
JP
Japan
Prior art keywords
infectious pathogen
composition
extracellular matrix
matrix material
interest
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009547231A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010516763A (ja
Filing date
Publication date
Priority claimed from US11/699,448 external-priority patent/US9308252B2/en
Application filed filed Critical
Publication of JP2010516763A publication Critical patent/JP2010516763A/ja
Publication of JP2010516763A5 publication Critical patent/JP2010516763A5/ja
Pending legal-status Critical Current

Links

JP2009547231A 2007-01-30 2007-05-25 感染性病原体又は毒素に関連する疾患のためのワクチンアジュバントとしての細胞外マトリックス物質 Pending JP2010516763A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/699,448 US9308252B2 (en) 2005-10-27 2007-01-30 Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins
PCT/US2007/069727 WO2008094276A1 (en) 2007-01-30 2007-05-25 Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins

Publications (2)

Publication Number Publication Date
JP2010516763A JP2010516763A (ja) 2010-05-20
JP2010516763A5 true JP2010516763A5 (cg-RX-API-DMAC7.html) 2012-11-22

Family

ID=39359947

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009547231A Pending JP2010516763A (ja) 2007-01-30 2007-05-25 感染性病原体又は毒素に関連する疾患のためのワクチンアジュバントとしての細胞外マトリックス物質

Country Status (6)

Country Link
US (3) US9308252B2 (cg-RX-API-DMAC7.html)
EP (1) EP2114444B1 (cg-RX-API-DMAC7.html)
JP (1) JP2010516763A (cg-RX-API-DMAC7.html)
CN (1) CN101730541B (cg-RX-API-DMAC7.html)
AU (1) AU2007345673A1 (cg-RX-API-DMAC7.html)
WO (2) WO2008094276A1 (cg-RX-API-DMAC7.html)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8257715B1 (en) 2004-08-26 2012-09-04 University Of Notre Dame Tissue vaccines and uses thereof
US8778360B2 (en) * 2005-10-27 2014-07-15 University Of Notre Dame Extracellular matrix cancer vaccine adjuvant
US8802113B2 (en) * 2005-10-27 2014-08-12 University Of Notre Dame Extracellular matrix cancer vaccine adjuvant
US9308252B2 (en) * 2005-10-27 2016-04-12 Cook Biotech, Inc. Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins
US8097419B2 (en) 2006-09-12 2012-01-17 Longhorn Vaccines & Diagnostics Llc Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009
US9481912B2 (en) 2006-09-12 2016-11-01 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and identifying nucleic acid sequences in biological samples
US8652782B2 (en) 2006-09-12 2014-02-18 Longhorn Vaccines & Diagnostics, Llc Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids
US8080645B2 (en) 2007-10-01 2011-12-20 Longhorn Vaccines & Diagnostics Llc Biological specimen collection/transport compositions and methods
US9683256B2 (en) 2007-10-01 2017-06-20 Longhorn Vaccines And Diagnostics, Llc Biological specimen collection and transport system
US11041215B2 (en) 2007-08-24 2021-06-22 Longhorn Vaccines And Diagnostics, Llc PCR ready compositions and methods for detecting and identifying nucleic acid sequences
US10004799B2 (en) 2007-08-27 2018-06-26 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
EP2772267B1 (en) 2007-08-27 2016-04-27 Longhorn Vaccines and Diagnostics, LLC Immunogenic compositions and methods
AU2008343745B2 (en) 2007-10-01 2012-05-10 Longhorn Vaccines & Diagnostics Llc Biological specimen collection and transport system and methods of use
US11041216B2 (en) 2007-10-01 2021-06-22 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples
US9283266B2 (en) * 2008-02-28 2016-03-15 University Of Notre Dame Metastasis inhibition preparations and methods
AU2009323766B2 (en) 2008-12-02 2016-10-06 Wave Life Sciences Ltd. Method for the synthesis of phosphorus atom modified nucleic acids
WO2010078478A1 (en) 2008-12-31 2010-07-08 Cook Biotech Incorporated Tissue adjuvants and medical products including the same
SG177564A1 (en) 2009-07-06 2012-02-28 Ontorii Inc Novel nucleic acid prodrugs and methods of use thereof
US8846059B2 (en) 2009-12-08 2014-09-30 University Of Notre Dame Extracellular matrix adjuvant and methods for prevention and/or inhibition of ovarian tumors and ovarian cancer
US20110150934A1 (en) * 2009-12-18 2011-06-23 University Of Notre Dame Ovarian Tumor Tissue Cell Preparations/Vaccines for the Treatment/Inhibition of Ovarian Tumors and Ovarian Cancer
EP2620428B1 (en) 2010-09-24 2019-05-22 Wave Life Sciences Ltd. Asymmetric auxiliary group
US9605019B2 (en) 2011-07-19 2017-03-28 Wave Life Sciences Ltd. Methods for the synthesis of functionalized nucleic acids
CA3207612A1 (en) 2012-01-26 2013-08-01 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
JP6246121B2 (ja) * 2012-07-13 2017-12-13 株式会社新日本科学 キラル核酸アジュバント
SG10201912895PA (en) 2012-07-13 2020-02-27 Wave Life Sciences Ltd Chiral control
JP6268157B2 (ja) 2012-07-13 2018-01-24 株式会社Ｗａｖｅ Ｌｉｆｅ Ｓｃｉｅｎｃｅｓ Ｊａｐａｎ 不斉補助基
CN103110943B (zh) * 2013-03-11 2014-11-26 浙江普康生物技术股份有限公司 一种可替代氢氧化铝的新型疫苗佐剂
JPWO2015108048A1 (ja) 2014-01-15 2017-03-23 株式会社新日本科学 抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤
EP3095460A4 (en) 2014-01-15 2017-08-23 Shin Nippon Biomedical Laboratories, Ltd. Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent
JPWO2015108047A1 (ja) 2014-01-15 2017-03-23 株式会社新日本科学 免疫誘導活性を有するキラル核酸アジュバンド及び免疫誘導活性剤
PT3094728T (pt) 2014-01-16 2022-05-19 Wave Life Sciences Ltd Desenho quiral
WO2016183292A1 (en) 2015-05-14 2016-11-17 Longhorn Vaccines And Diagnostics, Llc Rapid methods for the extraction of nucleic acids from biological samples
CN106860861B (zh) * 2017-03-03 2020-11-03 北京博辉瑞进生物科技有限公司 一种免疫增强组合物、制备方法及其应用
US12485166B2 (en) 2020-02-06 2025-12-02 Longhorn Vaccines And Diagnostics, Llc Vaccines for the treatment and prevention of zoonotic infections
CA3176187A1 (en) * 2020-04-22 2021-10-28 Clay Fette Compositions comprising extracellular material with antiviral activity and uses thereof
GB2700078A (en) 2020-10-20 2025-09-17 Longhorn Vaccines & Diagnostics Llc Immunogenic antigens
US20250375512A1 (en) * 2022-06-24 2025-12-11 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Use of matrix bound vesicles (mbv) as vaccine adjuvants

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2172903A (en) 1937-09-24 1939-09-12 Paul M Charping Electric lighting system
US3346401A (en) 1963-12-12 1967-10-10 Council Scient Ind Res Processing of raw intestines
AT261800B (de) 1966-08-22 1968-05-10 Braun Internat Gmbh B Verfahren zur Herstellung von röhrenförmigen, glatten bzw. mit einem Gewinde versehenen Gewebe-Blutgefäß-Prothesen
US3810473A (en) 1972-12-04 1974-05-14 Avicon Inc Liquid-laid, non-woven, fibrous collagen derived surgical web having hemostatic and wound sealing properties
US4578067A (en) 1982-04-12 1986-03-25 Alcon (Puerto Rico) Inc. Hemostatic-adhesive, collagen dressing for severed biological surfaces
US4502159A (en) 1982-08-12 1985-03-05 Shiley Incorporated Tubular prostheses prepared from pericardial tissue
EP0331786B1 (de) 1988-03-11 1994-08-03 CHEMOKOL G.b.R. Ing.-Büro für Kollagenprodukte Verfahren zur Herstellung von Kollagenmembranen für Hämostase, Wundbehandlung und Implantate
US4956178A (en) 1988-07-11 1990-09-11 Purdue Research Foundation Tissue graft composition
US4902508A (en) 1988-07-11 1990-02-20 Purdue Research Foundation Tissue graft composition
US5837269A (en) 1989-09-25 1998-11-17 University Of Utah Research Foundation Vaccine compositions and method for enhancing an immune response
US5336616A (en) 1990-09-12 1994-08-09 Lifecell Corporation Method for processing and preserving collagen-based tissues for transplantation
US6120991A (en) * 1990-10-30 2000-09-19 Fred Hutchinson Cancer Research Center Epiligrin, an epithelial ligand for integrins
US5281422A (en) 1991-09-24 1994-01-25 Purdue Research Foundation Graft for promoting autogenous tissue growth
US5507810A (en) 1991-10-07 1996-04-16 Osteotech, Inc. Processing of fibrous connective tissue
US5437287A (en) 1992-08-17 1995-08-01 Carbomedics, Inc. Sterilization of tissue implants using iodine
US5352463A (en) 1992-11-13 1994-10-04 Badylak Steven F Tissue graft for surgical reconstruction of a collagenous meniscus and method therefor
US5275826A (en) 1992-11-13 1994-01-04 Purdue Research Foundation Fluidized intestinal submucosa and its use as an injectable tissue graft
US5480424A (en) 1993-11-01 1996-01-02 Cox; James L. Heart valve replacement using flexible tubes
US5460962A (en) 1994-01-04 1995-10-24 Organogenesis Inc. Peracetic acid sterilization of collagen or collagenous tissue
US6156305A (en) 1994-07-08 2000-12-05 Baxter International Inc. Implanted tumor cells for the prevention and treatment of cancer
US6218166B1 (en) 1994-12-09 2001-04-17 John Wayne Cancer Institute Adjuvant incorporation into antigen carrying cells: compositions and methods
US5695998A (en) 1995-02-10 1997-12-09 Purdue Research Foundation Submucosa as a growth substrate for islet cells
US7361332B2 (en) 1995-03-17 2008-04-22 The Regents Of The University Of California Treating tumors using implants comprising combinations of allogeneic cells
US5554389A (en) 1995-04-07 1996-09-10 Purdue Research Foundation Urinary bladder submucosa derived tissue graft
CA2214407C (en) * 1995-04-07 2008-06-17 Purdue Research Foundation Tissue graft and method for urinary bladder reconstruction
US5733337A (en) 1995-04-07 1998-03-31 Organogenesis, Inc. Tissue repair fabric
US6406689B1 (en) 1995-10-03 2002-06-18 Frank W. Falkenberg Compositions and methods for treatment of tumors and metastatic diseases
PT914043E (pt) 1996-04-03 2004-02-27 Rogosin Inst Perolas de agarose-colagenio implantaveis contendo celulas que produzem um produto biologico difusivel e suas utilizacoes
US6277368B1 (en) 1996-07-25 2001-08-21 The Regents Of The University Of California Cancer immunotherapy using autologous tumor cells combined with cells expressing a membrane cytokine
US6206931B1 (en) 1996-08-23 2001-03-27 Cook Incorporated Graft prosthesis materials
ATE229810T1 (de) 1996-10-11 2003-01-15 Univ California Krebs immuntherapie unter verwendung von tumorzellen kombiniert mit lymphozytmischungen
US5782914A (en) 1996-11-29 1998-07-21 Bio-Vascular, Inc. Method for preparing heterogeneous tissue grafts
WO1998051337A2 (en) 1997-05-12 1998-11-19 Aphton Corporation Immunogenic compositions to the cck-b/gastrin-receptor and methods for the treatment of tumors
US6444229B2 (en) 1998-02-27 2002-09-03 Purdue Research Foundation Submucosa gel compositions
DE19916085A1 (de) * 1998-10-28 2000-05-04 Sonntag Hans Guenther Verfahren zur Herstellung eines antiviralen Mittels
GB9827103D0 (en) 1998-12-10 1999-02-03 Onyvax Ltd New cancer treatments
JP2000264900A (ja) 1999-03-16 2000-09-26 Hisamitsu Pharmaceut Co Inc 新規生理活性ペプチド
EP1723963A3 (en) 1999-03-16 2008-05-07 Thomas Jefferson University Hapten-conjugated tumour cells
US6105775A (en) * 1999-04-20 2000-08-22 Pakon, Inc. Sleeving system for photographic film negatives
EP1180031A4 (en) 1999-04-26 2004-04-07 Univ Emory NOSCAPIN DERIVATIVES FOR USE AS ADJUVANT COMPOSITIONS AND METHODS OF USE THEREOF
US7015205B1 (en) 1999-10-18 2006-03-21 St. Vincent's Hospital And Medical Center Of New York Melanoma vaccine and methods of making and using same
IT1318663B1 (it) 2000-08-02 2003-08-27 Mediolanum Farmaceutici Srl Membrane di collagene a due facce di cui una organizzata a livellomacromolecolare.
WO2003002165A1 (en) * 2001-06-28 2003-01-09 Cook Biotech Incorporated Graft prosthesis devices containing renal capsule collagen
WO2003017745A2 (en) * 2001-08-23 2003-03-06 Sciperio, Inc. Architecture tool and methods of use
US20060078540A1 (en) 2002-03-18 2006-04-13 Warren William L Dendritic cell nodes
FR2842822B1 (fr) 2002-07-26 2004-10-01 Roussy Inst Gustave Procede de preparation d'une matrice extracellulaire et son utilisation pour la culture de cellules tumorales
US7550004B2 (en) 2002-08-20 2009-06-23 Cook Biotech Incorporated Endoluminal device with extracellular matrix material and methods
WO2004017866A1 (en) 2002-08-20 2004-03-04 Cook Incorporated Stent graft with improved proximal end
CA2536923C (en) * 2003-09-04 2012-10-09 Cook Biotech Incorporated Extracellular matrix composite materials, and manufacture and use thereof
US8257715B1 (en) 2004-08-26 2012-09-04 University Of Notre Dame Tissue vaccines and uses thereof
US8475512B2 (en) 2005-05-17 2013-07-02 Cook Medical Technologies Llc Prosthetic valve devices and methods of making and using such devices
WO2007035843A2 (en) * 2005-09-21 2007-03-29 Dask Technologies, Llc Methods and compositions for organ and tissue functionality
US9308252B2 (en) 2005-10-27 2016-04-12 Cook Biotech, Inc. Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins
US8802113B2 (en) 2005-10-27 2014-08-12 University Of Notre Dame Extracellular matrix cancer vaccine adjuvant
US8778360B2 (en) 2005-10-27 2014-07-15 University Of Notre Dame Extracellular matrix cancer vaccine adjuvant
US7545569B2 (en) * 2006-01-13 2009-06-09 Avery Dennison Corporation Optical apparatus with flipped compound prism structures
CA2627364A1 (en) 2007-01-30 2008-07-30 University Of Notre Dame Du Lac Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins
US9283266B2 (en) 2008-02-28 2016-03-15 University Of Notre Dame Metastasis inhibition preparations and methods
US8846059B2 (en) 2009-12-08 2014-09-30 University Of Notre Dame Extracellular matrix adjuvant and methods for prevention and/or inhibition of ovarian tumors and ovarian cancer
US20110150934A1 (en) 2009-12-18 2011-06-23 University Of Notre Dame Ovarian Tumor Tissue Cell Preparations/Vaccines for the Treatment/Inhibition of Ovarian Tumors and Ovarian Cancer

Similar Documents

Publication Publication Date Title
JP2010516763A5 (cg-RX-API-DMAC7.html)
Hume et al. Platform technologies for modern vaccine manufacturing
Kallerup et al. Classification of vaccines
WO2008112344A3 (en) Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins
JP2008525423A5 (cg-RX-API-DMAC7.html)
TW200738257A (en) Vaccine
RU2007127993A (ru) Сахарид-конъюгатные вакцины
JP2003520248A5 (cg-RX-API-DMAC7.html)
JP2010535025A5 (cg-RX-API-DMAC7.html)
WO2009000825A3 (en) Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
TW200722101A (en) Novel composition
NZ598367A (en) Multiple vaccination including serogroup C meningococcus
CY1112280T1 (el) Συνθεση πολυδυναμου εμβολιου
JP2004501873A5 (cg-RX-API-DMAC7.html)
JP2010105968A5 (cg-RX-API-DMAC7.html)
JP2012501347A5 (cg-RX-API-DMAC7.html)
DK1725258T3 (da) Kombinationsvacciner med lav dosis Hib-konjugat
NZ591950A (en) Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition
MX2015002483A (es) Composiciones inmunogenicas.
WO2008039171A3 (en) Inactivating pathogens with hydrogen peroxide for vaccine production
JP2007529503A5 (cg-RX-API-DMAC7.html)
JP2011504535A5 (cg-RX-API-DMAC7.html)
WO2010012069A8 (en) Multivalent vaccines based on papaya mosaic virus and uses thereof
JP2004505992A5 (cg-RX-API-DMAC7.html)
JP2009514840A5 (cg-RX-API-DMAC7.html)